Kura Oncology, Inc. (KURA) vs Savara Inc. (SVRA)
A side-by-side comparison of Kura Oncology, Inc. and Savara Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KURA
Kura Oncology, Inc.
$10.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SVRA
Savara Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KURA vs SVRA
growth of $100 · dividends reinvested · last 9yKURA -4.3% (-0.5%/yr)SVRA -45.4% (-6.5%/yr)KURA compounded faster over this window
KURA SVRA
KURA vs SVRA: by the numbers
- •SVRA is the larger company ($953M vs $935M market cap).
- •Both run net losses; SVRA's is the smaller (0.00% vs -384.30% net margin).
Metrics side by side
Valuation
| Metric | KURA | SVRA |
|---|---|---|
| P/S ratio | 12.10 | N/A |
| P/B ratio | 19.30 | 6.63 |
Profitability
| Metric | KURA | SVRA |
|---|---|---|
| Gross margin | 94.73% | 0.00% |
| Operating margin | -449.94% | 0.00% |
| Net margin | -384.30% | 0.00% |
| ROE | -612.78% | -96.97% |
| ROIC | -67.13% | -82.30% |
Growth (annualized)
| Metric | KURA | SVRA |
|---|---|---|
| Total return CAGR (5Y) | -10.73% | 29.75% |
Frequently asked
- How have KURA and SVRA total returns compared?
- Over the past 5 years, KURA delivered -10.73% and SVRA delivered 29.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.